Composition for improving kidney function
A whey protein hydrolysate with specific properties addresses the need for improving renal function by reducing creatinine levels and increasing eGFR, offering a safe and effective solution for chronic kidney disease progression.
Patent Information
- Application Number
- JP2024210778
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-12-03
- Publication Date
- 2026-06-15
AI Technical Summary
Current treatments for chronic kidney disease focus on slowing disease progression and maintaining renal function, but there is a lack of effective compositions to improve renal function and reduce markers of kidney impairment such as creatinine levels and blood urea nitrogen (BUN).
A composition comprising a whey protein hydrolysate with specific physicochemical properties, including an average molecular chain length of 2 to 10, a fraction of 5,000 to 10,000 daltons of 8% or less, and free amino acids of 10% or less, is developed to improve renal function by reducing blood creatinine levels and increasing estimated glomerular filtration rate (eGFR).
The whey protein hydrolysate composition effectively reduces blood creatinine levels and increases eGFR, providing a safe and long-term solution for improving renal function in individuals with GFR classifications of G2 and G3, and can be used in both therapeutic and non-therapeutic settings.